Zepbound · Brand-name · 2026
Zepbound is Eli Lilly's FDA-approved tirzepatide. These programs prescribe the brand itself, not a compounded copy, and send the prescription to LillyDirect or a pharmacy.
The short answer
Self-pay Zepbound from Lilly is $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg with on-time refills. You still need a prescriber: we track 68 telehealth programs that write it. Providers we work with may appear first; each review itemizes the program's own fee.
Self-pay KwikPen prices from Lilly's coverage and savings page, October 2026. The $449 tier needs each refill within 45 days; the $25 figure is the savings card for commercial plans that cover Zepbound. A telehealth fee comes on top. Provider quotes below identify whether they cover medication, care, or both; starting doses and billing cycles can differ.
25 of 68 providers. CoreAge Rx is a featured partner; providers we work with may appear first. The Metabolic-Fit Score is printed on every row so you can check it.
A real telehealth marketplace with a video visit and a clinician you pick — now brand-first, so you get on-label Wegovy or Zepbound with the manufacturer's own pregnancy labeling, if you can absorb a membership fee stacked on the drug price.
The widest menu on our list — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, prices published for every plan length, and cancellation terms among the most restrictive we have read.
The most complete set of routes on our list — a real branded lane through insurance or LillyDirect, a compounded lane priced the same at every dose, and a non-GLP-1 generics lane — undercut by a three-day refund window and a complaint pattern that sits squarely on billing.
RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the typical price we track, and the oral capsules cost the same or more than the injections.
The closest thing here to a real obesity-medicine clinic online — board-certified physicians and registered dietitians, monthly video visits, and a real effort to work brand-name drugs through insurance. The $299 self-pay fee is for that clinical team, not the medication.
A women's-health practice first and a GLP-1 prescriber second: an OB-GYN or nurse practitioner, a registered dietitian and hormone labs on every case, check-ins every one to two weeks, and brand-name options from the Wegovy tablet to Zepbound. The $149 a month buys the care team, not the medication, which your own pharmacy and insurance price. Full care runs in 45 states plus DC; five more states get nutrition-only care with no prescribing.
An online primary-care practice rather than a weight-loss storefront: a board-certified doctor orders labs, prescribes brand-name GLP-1s such as Wegovy or Zepbound if you qualify, and handles the insurance prior authorization. A $19.99 monthly membership covers up to five family members, and visits are your copay or $129 without insurance. The medication's price is set by your pharmacy and plan, and PlushCare won't prescribe within six months of giving birth or while nursing.
The women's-health app many mothers already use for birth control, now writing brand-name GLP-1 prescriptions too: $79 for the consult, $79 a month for care, and the pen picked up at your own pharmacy. With insurance that can be a sensible setup. Without it, Nurx's own estimate for the pen starts around $1,000 a month, and Nurx does not take pregnant or breastfeeding patients.
Calibrate is an insurance-first program, not a cash pharmacy. You pay $199 a month for coaching, a video visit with a clinician, lab review and an app, with a three-month minimum ($597) before you can cancel. The medication is a separate bill. Its clinicians prescribe only brand-name GLP-1s (Wegovy, Zepbound, Mounjaro, the Foundayo pill) through your insurance, and Calibrate says most commercially insured members pay $25 a month or less once the deductible is met. Without coverage or with a high deductible, that number climbs fast. It serves all 50 states and DC, lists PCOS as a qualifying condition, and will not enroll anyone pregnant, breastfeeding or planning a pregnancy within the year.
A women's health company with a brand-only GLP-1 program: the membership is $39 the first month, then $150 a month, and the pharmacy bills the medication separately — Wegovy pill or Foundayo from $149, Wegovy pen from $199, Zepbound from $299. That puts the cheapest regular month at about $299 all-in. Clinicians review PCOS, perimenopause and recent pregnancy at intake, nutrition and strength coaches are included, and insurance advocates check whether your plan covers the drug. You can cancel any month with 48 hours' notice. No compounded option, and no state list is published.
A large, publicly traded telehealth company running a brand-name GLP-1 program: a $149 monthly program fee ($39 the first month) covers clinicians, coaching and labs, and the medication is billed on top, from $149 for the Wegovy pill to $299 for a Zepbound vial. Without insurance a standing month runs about $298 to $448; with coverage the drug can drop to a small copay. Medicare and Medicaid members are not eligible.
AskRx itemizes a $100 monthly care fee: $90 for the physician visit plus $10 fulfillment, with medication billed separately. It lists FDA-approved Wegovy, Zepbound and Foundayo (orforglipron), without compounded options. The pharmacy says medication is billed at cost, but no medication amount is published, so obtain the complete quote before choosing a plan.
Pallas charges $199 every four weeks for compounded semaglutide and $299 for tirzepatide, after first-month offers of $139 and $179. Lower annual-plan averages require a longer commitment; provider care and shipping are included.
9amHealth describes multidisciplinary care and FDA-approved brand medications, with a strong focus on diabetes management. A current medication-and-care total is not publicly established. The earlier $149 figure was a care fee, not the price of Wegovy or Zepbound; medication and insurance eligibility need separate confirmation.
An FDA warning letter dated September 2025, over the compounded-semaglutide business it has since left behind. One of the few mass-market brands designed around a woman's front door — now selling FDA-approved brand Wegovy and Zepbound instead of the compounded semaglutide it used to, though the posted price is only half the bill once the required $149/mo membership is added.
A menopause practice with a full GLP-1 shelf: a $99 monthly care fee buys menopause-trained doctors, dose adjustments and hormone-therapy coordination, and the medication is priced separately — compounded semaglutide from $70, compounded tirzepatide from $100, the Wegovy pill or Foundayo from $149, Zepbound from $299. That makes the lowest real month about $169, with $50 off the first care month for new customers. Compounded prices are floors with no published dose ladder, brand pens are paid to LillyDirect or NovoCare, and the care fee renews automatically unless you cancel seven days before the period ends. It takes no insurance and does not serve weight-care patients in Louisiana or Mississippi.
Brand-name GLP-1s behind a required membership: pills from $149 and Zepbound from $299, plus $149 a month for the membership, so the real month is about double the number on the card. Hims is the company's men's storefront; a mother signing up herself uses Hers, the women's brand of the same company. An FDA warning letter from September 2025 concerns how it marketed the compounded semaglutide it used to sell.
A menopause-care membership that also prescribes brand GLP-1s: $49 a month month to month, or as low as $35 on the annual plan, buys unlimited messaging with a menopause-trained clinician, and Wegovy, Ozempic, Rybelsus, Zepbound or Mounjaro go to your own pharmacy, where insurance can apply. The medication is never included and never priced on the site, so the real monthly cost is the membership plus whatever your pharmacy charges for the pen. It serves all 50 states and DC, takes major commercial insurance for video visits ($150 self-pay otherwise), and offers no compounded option.
Hello Alpha is the only provider on this page that was built as a women's health service first and a weight-loss service second, and that shows in what it will and will not do. It prescribes fda-approved products only — its own words are 'we only prescribe FDA-approved medications' — which means the Zepbound and Mounjaro pens and Rybelsus tablets, and no compounded semaglutide at all. For a mother weighing the compounding question that is the whole argument in one sentence: you are getting a finished drug made by the manufacturer, with the trade-off that you are also getting manufacturer pricing. What Hello Alpha publishes is $79 a month for its Alpha Plus+ membership, which buys appointment-free online visits, unlimited provider messaging and free shipping — the medication is billed on top of it, 'insurance or cash pay', and Hello Alpha says it will work with your plan to bring the cost down. No cash price for any medication appears anywhere on the site, so the honest reading is that $79 is your floor and the drug is the unknown. It is also candid that membership does not guarantee a prescription. If you have coverage, this is one of the few routes here that tries to use it; if you do not, the total is unknowable from the outside, and the compounded providers on this page will almost certainly be cheaper.
No compounded anything. PrideRx charges a service fee — $25 the first month, $99 after — and the manufacturer bills you for the drug: $299 for the Zepbound starter pen, $149 for the Wegovy pill, both straight from LillyDirect and NovoCare. It publishes those totals next to two competitors with a verification date on them. For a mother who wants an FDA-approved product and a clear fee, that is an unusually legible structure.
Ivim Health is one of the more hands-on GLP-1 programs out there: weekly app check-ins with dose changes from a provider, unlimited provider visits, functional health coaches and a women's hormone program, plus brand-name Wegovy or Zepbound through its traditional program. The catch is commitment. Compounded semaglutide works out to about $150 a month and tirzepatide about $208 only on a six-month program, once the required $74.99 monthly fee is added, and a program cannot be canceled once it starts. There is no month-to-month option. Ivim also holds a February 2026 FDA warning letter because labels on its site implied it compounded the medication itself. Compounded care isn't offered in every state, and no list is published.
A women's hormone and wellness brand (Joi, with a men's side called Blokes) that also sells compounded GLP-1s: semaglutide at $179 a month and tirzepatide at $249, after a $99 or $149 first month. The price covers the medication, clinician consults and unlimited health-coach visits, and it's billed quarterly. The product page says cancel anytime, yet the Terms require three consecutive months and make products non-refundable. The company holds a June 2026 FDA warning letter over how it marketed compounded semaglutide and tirzepatide. Brand Zepbound is a $99-a-month program with the vials bought from LillyDirect, and the same company offers HRT, thyroid care and lab panels.
The habit-coaching app many moms already have on their phone, now with clinicians and a long medication menu: compounded microdose semaglutide or tirzepatide, full-dose compounded tirzepatide, and brand-name Wegovy, the Wegovy pill, Zepbound, Ozempic, Mounjaro and Foundayo. The microdose plan is $79 to start, then $179 a month; full-dose tirzepatide is $149 to start, then $299 a month. Both bill on 12-week subscriptions plus tax and include the medication and the app. Brand-name care is $39 to start, then $129 a month, with the medicine paid through insurance or out of pocket. Prices sit in footnotes with different effective dates, the compounded plans skip some states, and no state list is published.
One of the lowest listed prices for compounded GLP-1s — $89 a month for semaglutide and $149 for tirzepatide, the same at every dose, with the visit, supplies and shipping included — from a company that received an FDA warning letter in June 2026 and treats every payment as final. Cancellation needs 72 hours' notice, and a documented trinitymeds trademark connection deserves attention.
| # | Provider | Zepbound | Score | |
|---|---|---|---|---|
| 1 | Sesame | From $398Drug + care | All 50 states | 81 · B− |
| 2 | ShedRx | From $349Drug only; care extra | All 50 states | 76 · C |
| 3 | Found Health | From $149Care only; drug extra | See review | 74 · C |
| 4 | RxSpan MD | See review | All 50 states | 57 · C |
| 5 | Form Health | See review | See review | 86 · B |
| 6 | Ro | See review | See review | 84 · B |
| 7 | Allara Health | See review | 45 states | 81 · B− |
| 8 | PlushCare | See review | All 50 states | 71 · C |
| 9 | Nurx | See review | See review | 70 · C |
| 10 | Calibrate | See review | All 50 states | 69 · C |
| 11 | Maven Clinic | From $449Drug + care | See review | 69 · C |
| 12 | LifeMD | From $448Drug + care | All 50 states | 66 · C |
| 13 | AskRx | See review | All 50 states | 65 · C |
| 14 | Pallas Health | See review | All 50 states | 65 · C |
| 15 | 9amHealth | See review | See review | 63 · C |
| 16 | Hers | From $448Drug + care | See review | 63 · C |
| 17 | Alloy | From $398Drug + care | See review | 62 · C |
| 18 | Hims | From $448Drug + care | See review | 60 · C |
| 19 | Evernow | See review | All 50 states | 58 · C |
| 20 | Hello Alpha | See review | All 50 states | 58 · C |
| 21 | PrideRx | From $398Drug + care | See review | 58 · C |
| 22 | Ivim Health | See review | See review | 57 · C |
| 23 | Joi + Blokes | See review | See review | 57 · C |
| 24 | Noom Med | See review | See review | 57 · C |
| 25 | altRx | See review | All 50 states | 56 · C |
Any licensed clinician can prescribe Zepbound, including a telehealth program. We track 68 programs whose own sites say they prescribe the brand; this board shows 25. The prescription is then filled by LillyDirect, a pharmacy the program uses, or your own pharmacy. Providers we work with may appear first.
Lilly's self-pay price is $299 a month for 2.5 mg and $399 for 5 mg. The 7.5 mg to 15 mg KwikPen doses are $449 a month when each refill is bought within 45 days of the last delivery; otherwise 7.5 mg is $499 and 10 mg to 15 mg are $699. A telehealth program usually adds its own visit or membership fee on top, and each review here itemizes that fee.
Yes. Lilly's savings card lets people with commercial insurance that covers Zepbound pay as little as $25 for a one-, two- or three-month fill, up to set monthly and yearly limits; the current card runs through December 31, 2026. It cannot be used with Medicare, Medicaid or other government coverage. Coverage first, then the card, then self-pay is the usual order to check.
The Zepbound label includes a milk-transfer study but no data on infant effects or milk production, and asks you and your clinician to weigh the benefits of breastfeeding against your need for the drug. It is not used in pregnancy, and it can make oral birth control less reliable for four weeks after you start and after each dose increase, so a backup or non-oral method is advised.
Rankings reflect our published methodology. This page is informational and not medical advice; compounded medications are not FDA-approved brand products, and GLP-1 medicines are not used in pregnancy or while trying to conceive. See our medical disclaimer. Some links here earn us a referral fee, walled off from the score — read our funding disclosure.
Keep exploring
Each board answers a different question a mother brings to GLP-1 care.